Immunic | VTL - Operating Expenses


Immunic reported $25.73M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 7.78M 3M Jun/2023
BioMarin Pharmaceutical USD 676.18M 131.65M Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.29M 1.51M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Enanta Pharmaceuticals USD 126.59M 346.51M Dec/2025
Grifols EUR 1.99B 217.4M Dec/2025
Immunic USD 25.73M 2.91M Sep/2024
Insmed USD 513.55M 109.86M Dec/2025
Omeros USD 59.16M 20.13M Jun/2024
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Ultragenyx Pharmaceutical USD 321M 9.82M Dec/2025
United Therapeutics USD 804.8M 5.79B Dec/2025
Xoma USD 22.84M 1.67M Sep/2024